Transarterial Radioembolization (TARE)
TARE is a Trans-catheter Intra-arterial procedure performed by the Interventional Radiologist for the treatment of Primary and Secondary Hepatic Cancers. In the TARE procedure, the radioactive substance is injected through the Hepatic Artery into the Liver Tumour directly with the help of a Catheter inserted into the Peripheral Artery. The injected radioactive substance gets deposited in the Tumour tissue and then locally emits radiation which destroys the Tumour cells.
TARE can be helpful for:
- Patients with unresectable HCC and a life expectancy of at least 3 months are considered for TARE
- Patients with HCC confined to the Liver with Tumours comprising less than 70% of the Liver volume
- Patients who are unsuitable for surgery or any other modalities of treatment
- TARE is also useful as an alternative to ablation and in facilitating the resection of BCLC (Barcelona Clinic Liver Cancer) stage-A Tumour.
- It has a promising treatment effect, particularly in patients with major vascular involvement.
Benefits of TARE:
- Improves quality of life and overall survival benefits
- Short stay in Hospital
- Quick recovery
- Safe and Effective
This treatment option is currently performed by a few doctors only. We are proud to announce that we have Dr M C Uthappa – Director of Interventional Radiology and Interventional Oncology, with us. Dr Uthappa has experience with over 13500 major interventional radiology cases. He is an expert in all types of Interventional radiology procedures for Liver Cancer including TARE, Percutaneous Ethanol Injection(PEI), RFA, TACE, DC bead Embolisation, Portal vein Embolisation and Radio Embolisation (SIRT).
